nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A4—Clonidine—glaucoma	0.198	0.353	CbGbCtD
Ofloxacin—SLC22A5—Clonidine—glaucoma	0.112	0.2	CbGbCtD
Ofloxacin—SLC22A6—Methazolamide—glaucoma	0.088	0.157	CbGbCtD
Ofloxacin—SLC22A6—Acetazolamide—glaucoma	0.0703	0.126	CbGbCtD
Ofloxacin—CYP1A2—Betaxolol—glaucoma	0.0592	0.106	CbGbCtD
Ofloxacin—CYP1A2—Clonidine—glaucoma	0.0324	0.058	CbGbCtD
Ofloxacin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.00174	0.588	CbGdCrCtD
Ofloxacin—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00155	0.0658	CbGpPWpGaD
Ofloxacin—ABCC1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00153	0.065	CbGpPWpGaD
Ofloxacin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.00121	0.412	CbGdCrCtD
Ofloxacin—TOP2A—Circadian rythm related genes—ATOH7—glaucoma	0.000868	0.0368	CbGpPWpGaD
Ofloxacin—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000646	0.0274	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000583	0.0247	CbGpPWpGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000576	0.0244	CbGpPWpGaD
Ofloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000443	0.0188	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000433	0.0184	CbGpPWpGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000421	0.0179	CbGpPWpGaD
Ofloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000403	0.0171	CbGpPWpGaD
Ofloxacin—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000394	0.0167	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000392	0.0166	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000371	0.0157	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—OPN4—glaucoma	0.000346	0.0147	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—IL1A—glaucoma	0.000329	0.014	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000327	0.0139	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000317	0.0134	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000301	0.0128	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000295	0.0125	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000295	0.0125	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000269	0.0114	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—glaucoma	0.000263	0.0112	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000262	0.0111	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000239	0.0101	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000232	0.00983	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000228	0.00968	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000222	0.00943	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000222	0.0094	CbGpPWpGaD
Ofloxacin—ABCC1—S1P1 pathway—VEGFA—glaucoma	0.000207	0.0088	CbGpPWpGaD
Ofloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000205	0.00869	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000199	0.00845	CbGpPWpGaD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.000197	0.00837	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000197	0.00834	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000191	0.00812	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TXN—glaucoma	0.000187	0.00795	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000185	0.00786	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000167	0.0071	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000167	0.00708	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000165	0.00702	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000163	0.00694	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000162	0.00688	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000162	0.00687	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00016	0.0068	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000158	0.00671	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000153	0.0065	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000152	0.00646	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00015	0.00635	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000148	0.0063	CbGpPWpGaD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000148	0.00629	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000145	0.00615	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000144	0.0061	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000139	0.00591	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—RAB8A—glaucoma	0.000136	0.00578	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000136	0.00577	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000133	0.00564	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000132	0.0056	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000128	0.00543	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000123	0.00522	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	0.000122	0.00519	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000122	0.00517	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000121	0.00515	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—OPTN—glaucoma	0.000118	0.00501	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000117	0.00496	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000113	0.00479	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000112	0.00477	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000112	0.00473	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000109	0.00464	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000109	0.00464	CbGpPWpGaD
Ofloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000109	0.00464	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000109	0.00464	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000109	0.00461	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000108	0.00459	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000107	0.00453	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000104	0.00442	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000102	0.00434	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.99e-05	0.00424	CbGpPWpGaD
Ofloxacin—Loss of consciousness—Clonidine—glaucoma	9.9e-05	0.000239	CcSEcCtD
Ofloxacin—Feeling abnormal—Brinzolamide—glaucoma	9.87e-05	0.000238	CcSEcCtD
Ofloxacin—Mental disorder—Betaxolol—glaucoma	9.87e-05	0.000238	CcSEcCtD
Ofloxacin—Pain—Pilocarpine—glaucoma	9.84e-05	0.000238	CcSEcCtD
Ofloxacin—Constipation—Pilocarpine—glaucoma	9.84e-05	0.000238	CcSEcCtD
Ofloxacin—Cough—Clonidine—glaucoma	9.83e-05	0.000237	CcSEcCtD
Ofloxacin—Dizziness—Apraclonidine—glaucoma	9.83e-05	0.000237	CcSEcCtD
Ofloxacin—Erythema—Betaxolol—glaucoma	9.81e-05	0.000237	CcSEcCtD
Ofloxacin—Malnutrition—Betaxolol—glaucoma	9.81e-05	0.000237	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.73e-05	0.00413	CbGpPWpGaD
Ofloxacin—Urticaria—Dorzolamide—glaucoma	9.68e-05	0.000234	CcSEcCtD
Ofloxacin—Epistaxis—Timolol—glaucoma	9.67e-05	0.000233	CcSEcCtD
Ofloxacin—Body temperature increased—Dorzolamide—glaucoma	9.63e-05	0.000232	CcSEcCtD
Ofloxacin—Abdominal pain—Dorzolamide—glaucoma	9.63e-05	0.000232	CcSEcCtD
Ofloxacin—Tension—Betaxolol—glaucoma	9.62e-05	0.000232	CcSEcCtD
Ofloxacin—Sinusitis—Timolol—glaucoma	9.62e-05	0.000232	CcSEcCtD
Ofloxacin—Dysgeusia—Betaxolol—glaucoma	9.6e-05	0.000232	CcSEcCtD
Ofloxacin—Chest pain—Clonidine—glaucoma	9.59e-05	0.000231	CcSEcCtD
Ofloxacin—Arthralgia—Clonidine—glaucoma	9.59e-05	0.000231	CcSEcCtD
Ofloxacin—Abdominal pain—Travoprost—glaucoma	9.59e-05	0.000231	CcSEcCtD
Ofloxacin—Agranulocytosis—Timolol—glaucoma	9.57e-05	0.000231	CcSEcCtD
Ofloxacin—Anxiety—Clonidine—glaucoma	9.56e-05	0.000231	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.55e-05	0.00405	CbGpPWpGaD
Ofloxacin—Asthenia—Acetazolamide—glaucoma	9.54e-05	0.00023	CcSEcCtD
Ofloxacin—Dizziness—Bimatoprost—glaucoma	9.53e-05	0.00023	CcSEcCtD
Ofloxacin—Nervousness—Betaxolol—glaucoma	9.53e-05	0.00023	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	9.52e-05	0.00023	CcSEcCtD
Ofloxacin—Urticaria—Brinzolamide—glaucoma	9.52e-05	0.00023	CcSEcCtD
Ofloxacin—Feeling abnormal—Pilocarpine—glaucoma	9.49e-05	0.000229	CcSEcCtD
Ofloxacin—Discomfort—Clonidine—glaucoma	9.48e-05	0.000229	CcSEcCtD
Ofloxacin—Vomiting—Apraclonidine—glaucoma	9.45e-05	0.000228	CcSEcCtD
Ofloxacin—Muscle spasms—Betaxolol—glaucoma	9.43e-05	0.000228	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Pilocarpine—glaucoma	9.41e-05	0.000227	CcSEcCtD
Ofloxacin—Hypersensitivity—Brimonidine—glaucoma	9.4e-05	0.000227	CcSEcCtD
Ofloxacin—Dry mouth—Clonidine—glaucoma	9.38e-05	0.000226	CcSEcCtD
Ofloxacin—Bradycardia—Timolol—glaucoma	9.37e-05	0.000226	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.37e-05	0.00398	CbGpPWpGaD
Ofloxacin—Dermatitis—Apraclonidine—glaucoma	9.36e-05	0.000226	CcSEcCtD
Ofloxacin—Headache—Apraclonidine—glaucoma	9.31e-05	0.000225	CcSEcCtD
Ofloxacin—Confusional state—Clonidine—glaucoma	9.27e-05	0.000224	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—GSTM1—glaucoma	9.25e-05	0.00392	CbGpPWpGaD
Ofloxacin—Vision blurred—Betaxolol—glaucoma	9.24e-05	0.000223	CcSEcCtD
Ofloxacin—Rhinitis—Timolol—glaucoma	9.23e-05	0.000223	CcSEcCtD
Ofloxacin—Oedema—Clonidine—glaucoma	9.19e-05	0.000222	CcSEcCtD
Ofloxacin—Tremor—Betaxolol—glaucoma	9.19e-05	0.000222	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—FAS—glaucoma	9.17e-05	0.00389	CbGpPWpGaD
Ofloxacin—Hallucination—Timolol—glaucoma	9.16e-05	0.000221	CcSEcCtD
Ofloxacin—Asthenia—Brimonidine—glaucoma	9.15e-05	0.000221	CcSEcCtD
Ofloxacin—Infection—Clonidine—glaucoma	9.13e-05	0.00022	CcSEcCtD
Ofloxacin—Abdominal pain—Pilocarpine—glaucoma	9.1e-05	0.00022	CcSEcCtD
Ofloxacin—Body temperature increased—Pilocarpine—glaucoma	9.1e-05	0.00022	CcSEcCtD
Ofloxacin—Ill-defined disorder—Betaxolol—glaucoma	9.1e-05	0.00022	CcSEcCtD
Ofloxacin—Diarrhoea—Acetazolamide—glaucoma	9.09e-05	0.00022	CcSEcCtD
Ofloxacin—Rash—Bimatoprost—glaucoma	9.08e-05	0.000219	CcSEcCtD
Ofloxacin—Dermatitis—Bimatoprost—glaucoma	9.08e-05	0.000219	CcSEcCtD
Ofloxacin—Oedema peripheral—Timolol—glaucoma	9.07e-05	0.000219	CcSEcCtD
Ofloxacin—Anaemia—Betaxolol—glaucoma	9.06e-05	0.000219	CcSEcCtD
Ofloxacin—Shock—Clonidine—glaucoma	9.04e-05	0.000218	CcSEcCtD
Ofloxacin—Connective tissue disorder—Timolol—glaucoma	9.04e-05	0.000218	CcSEcCtD
Ofloxacin—Pruritus—Brimonidine—glaucoma	9.03e-05	0.000218	CcSEcCtD
Ofloxacin—Headache—Bimatoprost—glaucoma	9.03e-05	0.000218	CcSEcCtD
Ofloxacin—Nervous system disorder—Clonidine—glaucoma	9.02e-05	0.000218	CcSEcCtD
Ofloxacin—Thrombocytopenia—Clonidine—glaucoma	9e-05	0.000217	CcSEcCtD
Ofloxacin—Hypersensitivity—Dorzolamide—glaucoma	8.98e-05	0.000217	CcSEcCtD
Ofloxacin—Tachycardia—Clonidine—glaucoma	8.97e-05	0.000217	CcSEcCtD
Ofloxacin—Hypersensitivity—Travoprost—glaucoma	8.94e-05	0.000216	CcSEcCtD
Ofloxacin—Skin disorder—Clonidine—glaucoma	8.93e-05	0.000216	CcSEcCtD
Ofloxacin—Hyperhidrosis—Clonidine—glaucoma	8.89e-05	0.000215	CcSEcCtD
Ofloxacin—Visual impairment—Timolol—glaucoma	8.87e-05	0.000214	CcSEcCtD
Ofloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.84e-05	0.00375	CbGpPWpGaD
Ofloxacin—Malaise—Betaxolol—glaucoma	8.84e-05	0.000213	CcSEcCtD
Ofloxacin—Nausea—Apraclonidine—glaucoma	8.83e-05	0.000213	CcSEcCtD
Ofloxacin—Hypersensitivity—Brinzolamide—glaucoma	8.82e-05	0.000213	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CA5A—glaucoma	8.82e-05	0.00374	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NARFL—glaucoma	8.82e-05	0.00374	CbGpPWpGaD
Ofloxacin—Vertigo—Betaxolol—glaucoma	8.81e-05	0.000213	CcSEcCtD
Ofloxacin—Syncope—Betaxolol—glaucoma	8.79e-05	0.000212	CcSEcCtD
Ofloxacin—Dizziness—Acetazolamide—glaucoma	8.79e-05	0.000212	CcSEcCtD
Ofloxacin—Anorexia—Clonidine—glaucoma	8.76e-05	0.000212	CcSEcCtD
Ofloxacin—Asthenia—Dorzolamide—glaucoma	8.74e-05	0.000211	CcSEcCtD
Ofloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.73e-05	0.0037	CbGpPWpGaD
Ofloxacin—Asthenia—Travoprost—glaucoma	8.7e-05	0.00021	CcSEcCtD
Ofloxacin—Palpitations—Betaxolol—glaucoma	8.67e-05	0.000209	CcSEcCtD
Ofloxacin—Pruritus—Dorzolamide—glaucoma	8.62e-05	0.000208	CcSEcCtD
Ofloxacin—Loss of consciousness—Betaxolol—glaucoma	8.62e-05	0.000208	CcSEcCtD
Ofloxacin—Eye disorder—Timolol—glaucoma	8.6e-05	0.000208	CcSEcCtD
Ofloxacin—Asthenia—Brinzolamide—glaucoma	8.59e-05	0.000207	CcSEcCtD
Ofloxacin—Hypotension—Clonidine—glaucoma	8.59e-05	0.000207	CcSEcCtD
Ofloxacin—Pruritus—Travoprost—glaucoma	8.58e-05	0.000207	CcSEcCtD
Ofloxacin—Tinnitus—Timolol—glaucoma	8.58e-05	0.000207	CcSEcCtD
Ofloxacin—Cough—Betaxolol—glaucoma	8.56e-05	0.000207	CcSEcCtD
Ofloxacin—Nausea—Bimatoprost—glaucoma	8.56e-05	0.000207	CcSEcCtD
Ofloxacin—Cardiac disorder—Timolol—glaucoma	8.54e-05	0.000206	CcSEcCtD
Ofloxacin—Hypersensitivity—Pilocarpine—glaucoma	8.48e-05	0.000205	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	8.48e-05	0.0036	CbGpPWpGaD
Ofloxacin—Pruritus—Brinzolamide—glaucoma	8.47e-05	0.000205	CcSEcCtD
Ofloxacin—Vomiting—Acetazolamide—glaucoma	8.45e-05	0.000204	CcSEcCtD
Ofloxacin—Dizziness—Brimonidine—glaucoma	8.44e-05	0.000204	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Clonidine—glaucoma	8.38e-05	0.000202	CcSEcCtD
Ofloxacin—Angiopathy—Timolol—glaucoma	8.35e-05	0.000202	CcSEcCtD
Ofloxacin—Chest pain—Betaxolol—glaucoma	8.35e-05	0.000202	CcSEcCtD
Ofloxacin—Myalgia—Betaxolol—glaucoma	8.35e-05	0.000202	CcSEcCtD
Ofloxacin—Arthralgia—Betaxolol—glaucoma	8.35e-05	0.000202	CcSEcCtD
Ofloxacin—Diarrhoea—Dorzolamide—glaucoma	8.34e-05	0.000201	CcSEcCtD
Ofloxacin—Headache—Acetazolamide—glaucoma	8.33e-05	0.000201	CcSEcCtD
Ofloxacin—Anxiety—Betaxolol—glaucoma	8.32e-05	0.000201	CcSEcCtD
Ofloxacin—Insomnia—Clonidine—glaucoma	8.32e-05	0.000201	CcSEcCtD
Ofloxacin—Immune system disorder—Timolol—glaucoma	8.31e-05	0.000201	CcSEcCtD
Ofloxacin—Diarrhoea—Travoprost—glaucoma	8.3e-05	0.0002	CcSEcCtD
Ofloxacin—Mediastinal disorder—Timolol—glaucoma	8.29e-05	0.0002	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	8.29e-05	0.0002	CcSEcCtD
Ofloxacin—Asthenia—Pilocarpine—glaucoma	8.26e-05	0.000199	CcSEcCtD
Ofloxacin—Paraesthesia—Clonidine—glaucoma	8.26e-05	0.000199	CcSEcCtD
Ofloxacin—Discomfort—Betaxolol—glaucoma	8.25e-05	0.000199	CcSEcCtD
Ofloxacin—Arrhythmia—Timolol—glaucoma	8.22e-05	0.000198	CcSEcCtD
Ofloxacin—Dyspnoea—Clonidine—glaucoma	8.2e-05	0.000198	CcSEcCtD
Ofloxacin—Diarrhoea—Brinzolamide—glaucoma	8.2e-05	0.000198	CcSEcCtD
Ofloxacin—Somnolence—Clonidine—glaucoma	8.17e-05	0.000197	CcSEcCtD
Ofloxacin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	8.17e-05	0.00347	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.17e-05	0.00347	CbGpPWpGaD
Ofloxacin—Dry mouth—Betaxolol—glaucoma	8.17e-05	0.000197	CcSEcCtD
Ofloxacin—Pruritus—Pilocarpine—glaucoma	8.14e-05	0.000197	CcSEcCtD
Ofloxacin—Alopecia—Timolol—glaucoma	8.13e-05	0.000196	CcSEcCtD
Ofloxacin—Confusional state—Betaxolol—glaucoma	8.07e-05	0.000195	CcSEcCtD
Ofloxacin—Mental disorder—Timolol—glaucoma	8.06e-05	0.000195	CcSEcCtD
Ofloxacin—Dizziness—Dorzolamide—glaucoma	8.06e-05	0.000194	CcSEcCtD
Ofloxacin—Rash—Brimonidine—glaucoma	8.04e-05	0.000194	CcSEcCtD
Ofloxacin—Dermatitis—Brimonidine—glaucoma	8.04e-05	0.000194	CcSEcCtD
Ofloxacin—Dizziness—Travoprost—glaucoma	8.02e-05	0.000194	CcSEcCtD
Ofloxacin—Malnutrition—Timolol—glaucoma	8.01e-05	0.000193	CcSEcCtD
Ofloxacin—Erythema—Timolol—glaucoma	8.01e-05	0.000193	CcSEcCtD
Ofloxacin—Oedema—Betaxolol—glaucoma	8e-05	0.000193	CcSEcCtD
Ofloxacin—Headache—Brimonidine—glaucoma	7.99e-05	0.000193	CcSEcCtD
Ofloxacin—Decreased appetite—Clonidine—glaucoma	7.99e-05	0.000193	CcSEcCtD
Ofloxacin—ABCC1—Disease—LRP12—glaucoma	7.98e-05	0.00339	CbGpPWpGaD
Ofloxacin—Infection—Betaxolol—glaucoma	7.95e-05	0.000192	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Clonidine—glaucoma	7.94e-05	0.000192	CcSEcCtD
Ofloxacin—Fatigue—Clonidine—glaucoma	7.93e-05	0.000191	CcSEcCtD
Ofloxacin—Dizziness—Brinzolamide—glaucoma	7.92e-05	0.000191	CcSEcCtD
Ofloxacin—Nausea—Acetazolamide—glaucoma	7.9e-05	0.000191	CcSEcCtD
Ofloxacin—Diarrhoea—Pilocarpine—glaucoma	7.88e-05	0.00019	CcSEcCtD
Ofloxacin—Shock—Betaxolol—glaucoma	7.87e-05	0.00019	CcSEcCtD
Ofloxacin—Tension—Timolol—glaucoma	7.86e-05	0.00019	CcSEcCtD
Ofloxacin—Pain—Clonidine—glaucoma	7.86e-05	0.00019	CcSEcCtD
Ofloxacin—Constipation—Clonidine—glaucoma	7.86e-05	0.00019	CcSEcCtD
Ofloxacin—Nervous system disorder—Betaxolol—glaucoma	7.85e-05	0.000189	CcSEcCtD
Ofloxacin—Dysgeusia—Timolol—glaucoma	7.85e-05	0.000189	CcSEcCtD
Ofloxacin—Thrombocytopenia—Betaxolol—glaucoma	7.84e-05	0.000189	CcSEcCtD
Ofloxacin—Tachycardia—Betaxolol—glaucoma	7.81e-05	0.000189	CcSEcCtD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—glaucoma	7.8e-05	0.00331	CbGpPWpGaD
Ofloxacin—Nervousness—Timolol—glaucoma	7.78e-05	0.000188	CcSEcCtD
Ofloxacin—Skin disorder—Betaxolol—glaucoma	7.77e-05	0.000188	CcSEcCtD
Ofloxacin—Vomiting—Dorzolamide—glaucoma	7.75e-05	0.000187	CcSEcCtD
Ofloxacin—Hyperhidrosis—Betaxolol—glaucoma	7.74e-05	0.000187	CcSEcCtD
Ofloxacin—Rash—Dorzolamide—glaucoma	7.68e-05	0.000185	CcSEcCtD
Ofloxacin—Dermatitis—Dorzolamide—glaucoma	7.67e-05	0.000185	CcSEcCtD
Ofloxacin—Rash—Travoprost—glaucoma	7.65e-05	0.000185	CcSEcCtD
Ofloxacin—Dermatitis—Travoprost—glaucoma	7.64e-05	0.000184	CcSEcCtD
Ofloxacin—Headache—Dorzolamide—glaucoma	7.63e-05	0.000184	CcSEcCtD
Ofloxacin—Anorexia—Betaxolol—glaucoma	7.63e-05	0.000184	CcSEcCtD
Ofloxacin—Vomiting—Brinzolamide—glaucoma	7.62e-05	0.000184	CcSEcCtD
Ofloxacin—Dizziness—Pilocarpine—glaucoma	7.61e-05	0.000184	CcSEcCtD
Ofloxacin—Headache—Travoprost—glaucoma	7.6e-05	0.000183	CcSEcCtD
Ofloxacin—Nausea—Brimonidine—glaucoma	7.58e-05	0.000183	CcSEcCtD
Ofloxacin—Feeling abnormal—Clonidine—glaucoma	7.58e-05	0.000183	CcSEcCtD
Ofloxacin—Rash—Brinzolamide—glaucoma	7.55e-05	0.000182	CcSEcCtD
Ofloxacin—Vision blurred—Timolol—glaucoma	7.55e-05	0.000182	CcSEcCtD
Ofloxacin—Dermatitis—Brinzolamide—glaucoma	7.55e-05	0.000182	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.54e-05	0.0032	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Clonidine—glaucoma	7.52e-05	0.000181	CcSEcCtD
Ofloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	7.51e-05	0.00319	CbGpPWpGaD
Ofloxacin—Headache—Brinzolamide—glaucoma	7.5e-05	0.000181	CcSEcCtD
Ofloxacin—Hypotension—Betaxolol—glaucoma	7.48e-05	0.000181	CcSEcCtD
Ofloxacin—Angioedema—Timolol—glaucoma	7.32e-05	0.000177	CcSEcCtD
Ofloxacin—Vomiting—Pilocarpine—glaucoma	7.32e-05	0.000177	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.31e-05	0.0031	CbGpPWpGaD
Ofloxacin—Urticaria—Clonidine—glaucoma	7.3e-05	0.000176	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.3e-05	0.0031	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Betaxolol—glaucoma	7.29e-05	0.000176	CcSEcCtD
Ofloxacin—Abdominal pain—Clonidine—glaucoma	7.27e-05	0.000175	CcSEcCtD
Ofloxacin—Body temperature increased—Clonidine—glaucoma	7.27e-05	0.000175	CcSEcCtD
Ofloxacin—Rash—Pilocarpine—glaucoma	7.26e-05	0.000175	CcSEcCtD
Ofloxacin—Dermatitis—Pilocarpine—glaucoma	7.25e-05	0.000175	CcSEcCtD
Ofloxacin—Insomnia—Betaxolol—glaucoma	7.24e-05	0.000175	CcSEcCtD
Ofloxacin—Nausea—Dorzolamide—glaucoma	7.24e-05	0.000175	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.22e-05	0.00306	CbGpPWpGaD
Ofloxacin—Headache—Pilocarpine—glaucoma	7.21e-05	0.000174	CcSEcCtD
Ofloxacin—Nausea—Travoprost—glaucoma	7.21e-05	0.000174	CcSEcCtD
Ofloxacin—Vertigo—Timolol—glaucoma	7.2e-05	0.000174	CcSEcCtD
Ofloxacin—Paraesthesia—Betaxolol—glaucoma	7.19e-05	0.000173	CcSEcCtD
Ofloxacin—Syncope—Timolol—glaucoma	7.18e-05	0.000173	CcSEcCtD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	7.17e-05	0.00304	CbGpPWpGaD
Ofloxacin—Dyspnoea—Betaxolol—glaucoma	7.14e-05	0.000172	CcSEcCtD
Ofloxacin—Nausea—Brinzolamide—glaucoma	7.11e-05	0.000172	CcSEcCtD
Ofloxacin—Palpitations—Timolol—glaucoma	7.08e-05	0.000171	CcSEcCtD
Ofloxacin—Dyspepsia—Betaxolol—glaucoma	7.05e-05	0.00017	CcSEcCtD
Ofloxacin—Loss of consciousness—Timolol—glaucoma	7.04e-05	0.00017	CcSEcCtD
Ofloxacin—Cough—Timolol—glaucoma	6.99e-05	0.000169	CcSEcCtD
Ofloxacin—Decreased appetite—Betaxolol—glaucoma	6.96e-05	0.000168	CcSEcCtD
Ofloxacin—Hypertension—Timolol—glaucoma	6.92e-05	0.000167	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Betaxolol—glaucoma	6.91e-05	0.000167	CcSEcCtD
Ofloxacin—Fatigue—Betaxolol—glaucoma	6.9e-05	0.000167	CcSEcCtD
Ofloxacin—Constipation—Betaxolol—glaucoma	6.84e-05	0.000165	CcSEcCtD
Ofloxacin—Pain—Betaxolol—glaucoma	6.84e-05	0.000165	CcSEcCtD
Ofloxacin—Nausea—Pilocarpine—glaucoma	6.84e-05	0.000165	CcSEcCtD
Ofloxacin—Arthralgia—Timolol—glaucoma	6.82e-05	0.000165	CcSEcCtD
Ofloxacin—Chest pain—Timolol—glaucoma	6.82e-05	0.000165	CcSEcCtD
Ofloxacin—Myalgia—Timolol—glaucoma	6.82e-05	0.000165	CcSEcCtD
Ofloxacin—Anxiety—Timolol—glaucoma	6.8e-05	0.000164	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	6.77e-05	0.000164	CcSEcCtD
Ofloxacin—Hypersensitivity—Clonidine—glaucoma	6.77e-05	0.000163	CcSEcCtD
Ofloxacin—Discomfort—Timolol—glaucoma	6.74e-05	0.000163	CcSEcCtD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	6.7e-05	0.00284	CbGpPWpGaD
Ofloxacin—Dry mouth—Timolol—glaucoma	6.67e-05	0.000161	CcSEcCtD
Ofloxacin—Asthenia—Clonidine—glaucoma	6.6e-05	0.000159	CcSEcCtD
Ofloxacin—Feeling abnormal—Betaxolol—glaucoma	6.6e-05	0.000159	CcSEcCtD
Ofloxacin—Confusional state—Timolol—glaucoma	6.59e-05	0.000159	CcSEcCtD
Ofloxacin—Anaphylactic shock—Timolol—glaucoma	6.54e-05	0.000158	CcSEcCtD
Ofloxacin—Oedema—Timolol—glaucoma	6.54e-05	0.000158	CcSEcCtD
Ofloxacin—Pruritus—Clonidine—glaucoma	6.5e-05	0.000157	CcSEcCtD
Ofloxacin—Infection—Timolol—glaucoma	6.5e-05	0.000157	CcSEcCtD
Ofloxacin—Shock—Timolol—glaucoma	6.43e-05	0.000155	CcSEcCtD
Ofloxacin—Nervous system disorder—Timolol—glaucoma	6.41e-05	0.000155	CcSEcCtD
Ofloxacin—Urticaria—Betaxolol—glaucoma	6.36e-05	0.000153	CcSEcCtD
Ofloxacin—Skin disorder—Timolol—glaucoma	6.35e-05	0.000153	CcSEcCtD
Ofloxacin—Body temperature increased—Betaxolol—glaucoma	6.33e-05	0.000153	CcSEcCtD
Ofloxacin—Hyperhidrosis—Timolol—glaucoma	6.32e-05	0.000153	CcSEcCtD
Ofloxacin—Diarrhoea—Clonidine—glaucoma	6.29e-05	0.000152	CcSEcCtD
Ofloxacin—Anorexia—Timolol—glaucoma	6.23e-05	0.00015	CcSEcCtD
Ofloxacin—Hypotension—Timolol—glaucoma	6.11e-05	0.000147	CcSEcCtD
Ofloxacin—Dizziness—Clonidine—glaucoma	6.08e-05	0.000147	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	6.06e-05	0.00257	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.01e-05	0.00255	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Timolol—glaucoma	5.96e-05	0.000144	CcSEcCtD
Ofloxacin—Insomnia—Timolol—glaucoma	5.91e-05	0.000143	CcSEcCtD
Ofloxacin—Hypersensitivity—Betaxolol—glaucoma	5.9e-05	0.000142	CcSEcCtD
Ofloxacin—Paraesthesia—Timolol—glaucoma	5.87e-05	0.000142	CcSEcCtD
Ofloxacin—Vomiting—Clonidine—glaucoma	5.85e-05	0.000141	CcSEcCtD
Ofloxacin—Dyspnoea—Timolol—glaucoma	5.83e-05	0.000141	CcSEcCtD
Ofloxacin—Somnolence—Timolol—glaucoma	5.81e-05	0.00014	CcSEcCtD
Ofloxacin—Rash—Clonidine—glaucoma	5.8e-05	0.00014	CcSEcCtD
Ofloxacin—Dermatitis—Clonidine—glaucoma	5.79e-05	0.00014	CcSEcCtD
Ofloxacin—Headache—Clonidine—glaucoma	5.76e-05	0.000139	CcSEcCtD
Ofloxacin—Dyspepsia—Timolol—glaucoma	5.76e-05	0.000139	CcSEcCtD
Ofloxacin—Asthenia—Betaxolol—glaucoma	5.74e-05	0.000139	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.69e-05	0.00241	CbGpPWpGaD
Ofloxacin—Decreased appetite—Timolol—glaucoma	5.68e-05	0.000137	CcSEcCtD
Ofloxacin—Pruritus—Betaxolol—glaucoma	5.66e-05	0.000137	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Timolol—glaucoma	5.65e-05	0.000136	CcSEcCtD
Ofloxacin—Fatigue—Timolol—glaucoma	5.64e-05	0.000136	CcSEcCtD
Ofloxacin—Pain—Timolol—glaucoma	5.59e-05	0.000135	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.52e-05	0.00234	CbGpPWpGaD
Ofloxacin—Diarrhoea—Betaxolol—glaucoma	5.48e-05	0.000132	CcSEcCtD
Ofloxacin—Nausea—Clonidine—glaucoma	5.46e-05	0.000132	CcSEcCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.44e-05	0.00231	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CCND2—glaucoma	5.42e-05	0.0023	CbGpPWpGaD
Ofloxacin—Feeling abnormal—Timolol—glaucoma	5.39e-05	0.00013	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Timolol—glaucoma	5.35e-05	0.000129	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.35e-05	0.00227	CbGpPWpGaD
Ofloxacin—Dizziness—Betaxolol—glaucoma	5.29e-05	0.000128	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.28e-05	0.00224	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.2e-05	0.00221	CbGpPWpGaD
Ofloxacin—Urticaria—Timolol—glaucoma	5.19e-05	0.000125	CcSEcCtD
Ofloxacin—Body temperature increased—Timolol—glaucoma	5.17e-05	0.000125	CcSEcCtD
Ofloxacin—Abdominal pain—Timolol—glaucoma	5.17e-05	0.000125	CcSEcCtD
Ofloxacin—ABCC1—Disease—FGFR1OP—glaucoma	5.14e-05	0.00218	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HEYL—glaucoma	5.14e-05	0.00218	CbGpPWpGaD
Ofloxacin—Vomiting—Betaxolol—glaucoma	5.09e-05	0.000123	CcSEcCtD
Ofloxacin—Rash—Betaxolol—glaucoma	5.05e-05	0.000122	CcSEcCtD
Ofloxacin—Dermatitis—Betaxolol—glaucoma	5.04e-05	0.000122	CcSEcCtD
Ofloxacin—Headache—Betaxolol—glaucoma	5.01e-05	0.000121	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.93e-05	0.00209	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2B—glaucoma	4.86e-05	0.00206	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Timolol—glaucoma	4.82e-05	0.000116	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.78e-05	0.00203	CbGpPWpGaD
Ofloxacin—Nausea—Betaxolol—glaucoma	4.75e-05	0.000115	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.73e-05	0.00201	CbGpPWpGaD
Ofloxacin—Asthenia—Timolol—glaucoma	4.69e-05	0.000113	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.67e-05	0.00198	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.67e-05	0.00198	CbGpPWpGaD
Ofloxacin—Pruritus—Timolol—glaucoma	4.63e-05	0.000112	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.61e-05	0.00196	CbGpPWpGaD
Ofloxacin—Diarrhoea—Timolol—glaucoma	4.47e-05	0.000108	CcSEcCtD
Ofloxacin—Dizziness—Timolol—glaucoma	4.32e-05	0.000104	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CA1—glaucoma	4.31e-05	0.00183	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CTSA—glaucoma	4.17e-05	0.00177	CbGpPWpGaD
Ofloxacin—Vomiting—Timolol—glaucoma	4.16e-05	0.0001	CcSEcCtD
Ofloxacin—Rash—Timolol—glaucoma	4.12e-05	9.95e-05	CcSEcCtD
Ofloxacin—Dermatitis—Timolol—glaucoma	4.12e-05	9.94e-05	CcSEcCtD
Ofloxacin—Headache—Timolol—glaucoma	4.1e-05	9.89e-05	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.05e-05	0.00172	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CA2—glaucoma	3.94e-05	0.00167	CbGpPWpGaD
Ofloxacin—Nausea—Timolol—glaucoma	3.88e-05	9.37e-05	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.88e-05	0.00165	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.85e-05	0.00163	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.85e-05	0.00163	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.81e-05	0.00162	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.76e-05	0.00159	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.57e-05	0.00152	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.56e-05	0.00151	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—glaucoma	3.43e-05	0.00146	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NARFL—glaucoma	3.35e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA5A—glaucoma	3.35e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.33e-05	0.00141	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.33e-05	0.00141	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—HDAC9—glaucoma	3.21e-05	0.00136	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	3.11e-05	0.00132	CbGpPWpGaD
Ofloxacin—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.04e-05	0.00129	CbGpPWpGaD
Ofloxacin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3e-05	0.00127	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN2A—glaucoma	2.78e-05	0.00118	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—TXN—glaucoma	2.78e-05	0.00118	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.75e-05	0.00117	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.53e-05	0.00107	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.51e-05	0.00106	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—CDKN1B—glaucoma	2.46e-05	0.00104	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTT1—glaucoma	2.15e-05	0.000913	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.74e-05	0.000736	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN2B—glaucoma	1.73e-05	0.000732	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCA1—glaucoma	1.72e-05	0.000728	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CYP1B1—glaucoma	1.72e-05	0.000728	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA1—glaucoma	1.64e-05	0.000694	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CTSA—glaucoma	1.58e-05	0.000672	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—glaucoma	1.55e-05	0.000656	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CA2—glaucoma	1.5e-05	0.000635	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.46e-05	0.000621	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.46e-05	0.000621	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—MTHFR—glaucoma	1.45e-05	0.000614	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—GSTM1—glaucoma	1.37e-05	0.000582	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—APOE—glaucoma	1.35e-05	0.000572	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CAV1—glaucoma	1.33e-05	0.000566	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—BAD—glaucoma	1.26e-05	0.000533	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—MTHFR—glaucoma	1.21e-05	0.000514	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—APOE—glaucoma	1.13e-05	0.000479	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CAV1—glaucoma	1.12e-05	0.000474	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—TXN—glaucoma	1.05e-05	0.000447	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—NOS3—glaucoma	1.01e-05	0.000428	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.62e-06	0.000408	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.53e-06	0.000404	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—glaucoma	9.23e-06	0.000392	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CDKN1B—glaucoma	8.74e-06	0.000371	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—NOS3—glaucoma	8.45e-06	0.000359	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTT1—glaucoma	8.18e-06	0.000347	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—glaucoma	7.73e-06	0.000328	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.59e-06	0.00028	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CYP1B1—glaucoma	6.51e-06	0.000276	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCA1—glaucoma	6.51e-06	0.000276	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—GSTM1—glaucoma	5.21e-06	0.000221	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—MTHFR—glaucoma	4.6e-06	0.000195	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—APOE—glaucoma	4.28e-06	0.000182	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CAV1—glaucoma	4.24e-06	0.00018	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—NOS3—glaucoma	3.21e-06	0.000136	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—glaucoma	2.94e-06	0.000125	CbGpPWpGaD
